CABFIDENCE: Global Real-World Evidence Cohort Study to evaluate Utilization, Clinical and Patient-Reported Outcomes among CAB+RPV LA users (224047)

Study identification

• EU PAS number:
  EUPAS1000000616
• Study ID:
  1000000616
• Official title and acronym:
  CABFIDENCE: Global Real-World Evidence Cohort Study to evaluate Utilization, Clinical and Patient-Reported Outcomes among CAB+RPV LA users (224047)
• DARWIN EU® study:
  No
• Study countries:
  Australia

  Canada

  France

  Germany

  Italy

  Japan

  Korea, Republic of

  Portugal

  Spain

  Taiwan

  United Kingdom

  United States
• Study description:
  No information provided.
• Study status:
  Ongoing

Research institutions and networks

Institutions

ViiV Healthcare

Study timelines

Date when funding contract was signed

Planned:31/12/2024

Actual:06/12/2024

Study start date

Planned:31/12/2025

Actual:24/12/2025

Date of final study report

Planned:31/10/2029

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

ViiV Healthcare

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable